Regeneron Pharmaceuticals Inc at Barclays Global Healthcare Conference (Virtual) Transcript
Okay. Great. Well, good morning. Welcome to day 2 of the Barclays Global Health Care Conference. I am Carter Gould, Senior Biopharma analyst here. I am pleased to welcome Regeneron to the next session kicking off day 2. Representing the company is Marion McCourt, she heads up the commercial effort. She's joined today by Justin Holko, who runs the IR squad.
Marion and Justin are going to make some opening comments, and then we'll jump into questions. Justin you are on mute.
Well, thank you for that. Carter, thank you for the invitation. And before we begin, we'd like to remind you that remarks made on today's webcast do include forward-looking statements about Regeneron. Each forward-looking statement is subject to risks and uncertainties that could cause actual results and events to differ materially from those projected in the statement. More complete description of these and other material risks can be found in Regeneron
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
